Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-11-11 to 2024-11-12
Current total value of award: $5254.58
Description: 4566395800!QUILLIVANT XR ORAL SUSP 150ML 5MG/ML